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In infected cells, virus components must be organized at the right place and time to 
ensure assembly of infectious virions. From a different perspective, assembly must be 
prevented until all components are available.  Hypothetically, this can be achieved by 
allosterically controlling assembly. Consistent with this hypothesis, here we show that 
the structure of hepatitis B virus (HBV) core protein dimer, which can spontaneously 
self-assemble, is incompatible with capsid assembly. Systematic differences between 
core protein in dimer and capsid conformations demonstrate linkage between the 
intradimer interface and interdimer contact surface. These structures also provide 
explanations for the capsid-dimer selectivity of some antibodies and activity of assembly 
effectors. Solution studies suggest that the assembly-inactive state is more accurately 
an ensemble of conformations. Simulations show that allostery supports controlled 
assembly and results in capsids that are resistant to dissociation. We propose that 




Viruses are incredibly efficient molecular machines. It is not surprising that they have 
certain commonalities in their lifecycles. For example, most of them self-assemble to 
specifically encapsidate the right components in a crowded and complex intracellular 
environment. They interact with host cells to enter the host and to traffick therein. Even 
under less than ideal circumstances, they persist while between hosts.  It is likely that 
the physical basis for these common behaviors is based on a few common 
mechanisms. The critical hypothesis addressed in this paper is whether virus capsid 
assembly is subject to allosteric regulation. Allostery would explain how capsid proteins 
avoid packaging the wrong nucleic acid to unproductively assemble into extremely 
stable dead end complexes. Conversely allostery provides a mechanism for selectively 
packaging the correct content. As such, allostery may be generalizable to any self-
assembling virus. 
 
Hepatitis B virus (HBV) is one of the most widespread infectious public health problems 
(43). HBV has infected two billion people, 360 million chronically, and it leads to 
approximately 600,000 deaths each year (44). The virus itself, among the smallest 
human pathogens, has an unusual lifecycle that is critically dependent on accurate 
assembly. The immature core of this DNA virus is composed of an icosahedral capsid 
containing the RNA pregenome (the RNA template for the viral genome), reverse 
transcriptase, and some host proteins (21). The core assembles in the cytoplasm, after 
which the linear ssRNA pregenome is reverse transcribed within the core to generate 
the circular partially dsDNA genome of the infectious particle (21, 35, 38).  
 
The predominant form of the HBV capsid is constructed from 120 copies of the 
homodimeric core protein (Cp; also known as the core antigen, or HBcAg) arranged 
with icosahedral symmetry (Figure 1). The local quaternary arrangement in a capsid is a 
lattice of triangles, i.e. trimers of dimers (15). Cp itself is a 183-residue protein 
comprised of a 149-residue assembly domain and a 34-residue RNA-binding C-
terminus. Cp dimers are held together by a 4-helix bundle (amino acids 49 – 109), with 
two helices contributed by each half-dimer. This bundle forms the spikes that punctuate 
the virus surface (5, 48). The dimer interface also incorporates a pair of conserved 
cysteines that can form a stabilizing, but not required, disulfide (34, 52). The inter-dimer 
contact is a helix-turn-extended structure (amino acids 111-143) that “shingles” around 
icosahedral fivefold and quasi-sixfold vertices. The RNA-binding domain (amino acids 
150-183), which appears disordered based on image reconstructions (57), also has 
roles in signaling intracellular transport of the virus (49). In heterologous expression 
systems, the RNA-binding domain tenaciously binds and encapsidates random host 
RNA (2).  
 
 4 
Self-assembly has been demonstrated using the 149-residue assembly domain (Cp149) 
of the homodimeric core protein (2, 11, 12, 40, 41, 46). Based on kinetic analysis of in 
vitro assembly reactions, the formation of a trimer of Cp dimers has been identified as 
the nucleating event of assembly (58).  Evidence indicates that Cp undergoes 
conformational change(s) associated with assembly. It has been suggested that the 
surprisingly weak inter-dimer association energy in capsids is due to the energetic 
expense of a conformational change related to assembly (12). Further support for 
conformational change comes from observations of ions, peptides, and small molecules 
that bind to Cp. Zinc ions are bound cooperatively by Cp dimers and stimulate assembly 
kinetics, promoting kinetic traps (41). Similarly, a cooperative change in dimer structure 
was induced by a capsid-binding peptide, observed in NMR studies (20). Cooperative 
effects strongly imply concerted structural changes concomitant with binding.  HAP 
molecules, a family of assembly effectors, activate assembly both kinetically and 
thermodynamically (40, 42); assembly at an inappropriate time or place has great 
potential as an antiviral strategy. HAPs overfill a cavity at the interdimer contact, 
explaining their thermodynamic effect and ability to misdirect assembly (5), but not their 
kinetic effect, which has been proposed to be the result of an assembly activating 
conformational change.  However, any change must be relatively subtle as CD (39, 45) 
and NMR (20) spectroscopy indicate little change in secondary structure between dimer 
and capsid states. Immunological results are consistent with in vitro studies: though the 
tips of the intradimer spikes are the major antigenic region in both capsids and free 
dimer, some antibodies are specific for one form or the other (37). 
 
These results have led to the led to the hypothesis that HBV assembly is subject to 
allosteric regulation (2, 11, 12, 40, 41, 46). That is, the structure of free Cp dimer is not 
compatible with assembly and that a structural transition activates the assembly 
reaction. This mechanism would minimize inappropriate assembly. Furthermore, it 
implies that some molecule(s), assembly effectors, induce the transition. Though they 
show less fidelity for forming regular structures, similar allosteric mechanisms have also 
been implicated in retrovirus assembly (16, 17, 26, 29, 31). However, the structural 
basis of allostery in regulating virus assembly has not previously been demonstrated. 
 
To test the allostery hypothesis we have determined the structure of dimeric Cp out of 
the context of capsid. To do so, we developed an assembly incompetent form of dimeric 
Cp, Cp149-Y132A (7). Y132 is almost completely buried in capsid, accounting for nearly 
10% of the total buried surface area (48), but should be completely exposed in free 
dimer. Thus, unless dimeric Cp149 is completely refolded compared to the capsid form, 
it is unlikely that the mutation Y132A will affect dimer structure. Cp149-Y132A has been 
purified as a dimer and has circular dichroism, fluorescence, and chromatographic 
properties that are essentially identical to those of wildtype.  By itself, Cp149-Y132A is 
assembly incompetent (28), even under conditions where the wildtype assembly domain 
assembles nearly quantitatively (7). However, Cp149-Y132A will co-assemble with 
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wildytpe protein to yield extremely fragile capsids (7). Here we examine the structure of 




Protein purification  
Cp149-Y132A expression and purification was performed as previously described (7) 
except the final ion exchange step. Partly purified Cp149-Y132A in QA buffer (buffer 
QA: 50 mM Tris HCl pH 9.0, 80 mM NaCl, 2 mM DTT) was adsorbed to a HiTrap Q 
column (GE Health sciences) and eluted in a multistep gradient with buffer QB (50 mM 
Tris HCl pH 9.0, 2 M NaCl, 2 mM DTT).  The sample was initially loaded on a 5 ml 
column and washed with 5 volumes of buffer QA. This was followed by a 0 - 5% buffer 
QB gradient in 2 column volumes, a 5-10% QB gradient in 10 column volumes wherein 
Cp149-Y132A elutes, followed by a 10-30% QB gradient in 10 column volumes, 30 - 
100% QB in 2 volumes, and then 5 column volumes of 100% QB to clear the column. 
Fractions were pooled based on SDS-PAGE and absorbance, concentrated to at least 8 
mg/ml, and then dialyzed into 10mM Tris HCL pH 9.0, 2 mM DTT.  Cp149-C61S was 
purified as previously described for Cp149 WT (59). 
 
Crystallization and structure determination 
Crystals of Cp149-Y132A were grown from a 10 mg/ml solution of Cp in 50mM Tris HCl 
pH 9.0 in an equal volume of precipitating solution of 100 mM sodium cacodylate  pH 
6.5, 9% PEG 1500, 0.1 M calcium acetate. Small rhombohedral crystals were 
transferred to synthetic mother liquor with 20% glycerol immediately prior to freezing at 
liquid nitrogen temperatures. Crystallographic data were collected on a Rigaku 3HR X-
ray source equipped with an R-axis IV++ detector at a crystal to detector distance of 
150mm. Diffraction data were indexed, integrated and scaled with the HKL2000 (36). 
Crystals belonged to space group P31 with cell dimensions of a = b = 104.16 Å, c = 
86.91 Å   α= β =90° γ =120°. We also collected data on similar crystals but to lower 
resolution, with no significant structural differences. 
 
The structure was determined by molecular replacement. Initial phases were obtained 
using PHASER (32) using atomic coordinates of one AB dimer of HBV core protein from 
a capsid (PDB id: 1QGT) (48). The 1QGT structure was chosen as the highest 
resolution HBV structure available. The initial structure determination was performed 
with a 2.9 Å data set. The first stages of structure refinement were performed using 
REFMAC 5.0(33, 47) implemented in the CCP4 suite (13). About 5% of the reflections 
were used for the test set. An initial examination of the asymmetric unit showed that 
subunits were not arranged with point symmetry or in a continuous helix, thus we did 
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not use molecular averaging to improve phases. The resultant model obtained from the 
structure solution was subjected to rigid body refinement first using individual proteins 
and then protein fragments, which led to an R-factor of 42.2% (Rfree= 46.0%). The 
improved model was subject to restrained refinement with REFMAC followed by manual 
rebuilding with COOT (18), which brought the R factor to 24.7% (Rfree 30.9%). After 
several iterations of rebuilding with COOT and restrained refinement with REFMAC, 
further refinement and energy minimization was performed with CNS 1.2  (9). This 
model was then applied to a newly acquired 2.25 Å data set and a similar process of 
molecular replacement from PHASER to CNS was followed. In the refined model, 
improved with iterative rounds of model building, there remained areas of weak density, 
the spike tips for the A, B, C, and D subunits (but not E and F) and the C-terminus of the 
A subunit, that were iteratively rebuilt making use of omit maps to eliminate model bias. 
Finally 213 water molecules were added, which lead to a final R-factor of 21.7% (Rfree 
= 26.4%). Density was unambiguous for the main chain from residue 1 to at least 141 
for all six polypeptides (see Supplementary Figures S1, S2). The Ramachandran plot 
for the final model calculated using the program PROCHECK (30), which shows only 
1.1% of φψ angles were in disallowed regions, 89.1% of the residues in the most 
favored region and the remaining residues in the additionally allowed regions. Residues 
in the disallowed regions were from regions of poorly defined density also characterized 
by high B factors: the A, C, and D spike tips and the C-terminal extended region of the A 
chain. Statistics for the data set used in this structure determination and the final refined 
structure are detailed in Table 1.  
 
Assembly studies 
Co-assembly reactions were carried out in at either 23°C or 37°C in 50mM HEPES pH 
7.5 in the presence or absence of 5% β-mercaptoethanol.  Assembly was initiated by 
the addition of 2x NaCl to a final concentration of 0.5M.  Long term kinetics of assembly 
were observed using size-exclusion chromatography performed using a 21mL Superose 
6 column equilibrated in 50mM HEPES pH 7.5 and 1.0 M NaCl.  The column was 
mounted on a Shimadzu-HPLC system equipped with a temperature-controlled auto-
injector in order to facilitate the long time course.  Peaks at 280nm were quantified after 
manual baseline correction using the supplied LCSolutions software (Shimadzu). 
 
Kinetic modeling 
Mathematical models are based on a master equation approach that treats assembly 
and disassembly as a completely reversible cascade of second order reactions. The 
underlying math has been extensively reviewed (19). The equations used in this study 
are for an icosahedral structure assembled from 30 tetravalent “dimers” (19). The 
“dimers” are designed to resemble the HBV subunit topology. For computational 
simplicity, only a single forward and backward path were allowed. Similar models have 
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been used to qualitatively fit the assembly of HBV (41, 58) and Cowpea Chlorotic Mottle 




The crystallographic asymmetric unit suggests aborted self-assembly 
Cp149-Y132A crystallizes under conditions that are conducive to assembly of the 
wildtype Cp149 (see methods); under these same conditions the mutant does not 
assemble into capsid. Crystals diffracted to 2.25Å, allowing in house collection of a high 
quality data set and a reliable molecular replacement solution of the structure based on 
a dimer from capsid (Table 1). The crystallographic asymmetric unit is a trimer of 
Cp149-Y132A dimers (Figure 1b, c) that is suggestive of an abortive assembly 
intermediate or nucleation complex (58). The trimer itself resembles the quaternary 
arrangement of dimers in capsid (Figure 1). The crystallographically unique dimers, 
named AB, CD, and EF, are at first glance structurally similar to dimers from capsid 
(Figure 1, 2). However, unlike a trimer that might be extracted from a capsid, the 
crystallographic asymmetric unit is not a closed triangle. Instead, the asymmetric unit is 
a one turn left-handed helix.  
 
The trimer of dimers in the asymmetric unit has two capsid-like interdimer contacts, the 
B-C and D-E junctions (Figure 1). There is no F-A contact. The two junctions cover the 
same respective surfaces as in capsid, although the Y132A mutation allows closer 
interaction than observed in capsids (5, 48). The lack of closure of the trimer results 
largely from changes in dimer geometry (detailed in the following paragraphs) that are 
propagated by quaternary structure. Clearly this broken triangle with two contacts, 
rather than a closed triangle with three contacts, is stable enough to persist as the 
crystallographic asymmetric unit. This suggests that closure of the triangle, as seen in 
capsids, represents a compromise between the stability of dimer geometry and energy 
obtained by forming one more interdimer contact.  This is compromise can be described 
explicitly, comparing the energy of triangle and asymmetric unit formation:  
 
1) ∆G°triangle = 3∆G°contact + 3∆G°conformational change 
 
Whereas the weaker contact interaction of Cp149-Y132A results in an asymmetric unit 
where the association energy, neglecting crystal packing contacts, is 
 
2)  ∆G°asymmetric unit = 2∆G°contact   
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For the Cp149-Y132A mutant, we observe that ∆G°asymmetric unit < ∆G°triangle, that is the 
broken triangle is favored over the closed triangle, which leads to the conclusion that 
∆G°conformational change is positive. 
 
Conformations of free dimers are distinct from dimers in capsid 
Cp149-Y132A has distinct structural differences from subunits extracted from a capsid 
that are not directly related to the mutation itself. The comparison of the Y132A and 
capsid structures is most readily viewed from the perspective of dimers. First consider 
the capsid structure: the four classes of monomer from a T=4 capsid, A, B, C, and D, 
are nearly identical to one another; the AB and CD dimers show well-preserved twofold 
symmetry (5, 48). This similarity results in an RMSD between dimers of about 1 Å, in 
either orientation.   
 
In contrast, the Cp149-Y132A AB, CD, and EF dimers are asymmetric and show 
obvious differences from one another localized to (i) the upper half of the four helix 
bundle that forms the “spikes” at the dimer interface and (ii) the orientation of the C-
terminal interdimer contact domain (Figure 2a, d). The spike tips have two different 
conformations in every dimer, an obvious difference from the capsid form. In the B, C, 
and F half-dimers, the spike tip is capsid-like. In A, D, and E half-dimers residues 79-81 
are unraveled from a helical conformation but are relatively upright (Figure 2d and 
Supplementary Figures S1, S2). Thus, all spike tips show a large displacement 
compared to capsid (Fig 2c). There is no obvious reason that the different 
conformations are not in sequence (e.g. alternating capsid-like / unraveled spike tip). 
The loops at the tips of the spikes also vary in their crystallographic order, with the 
clearest density for the EF spike tip.  The structural change at the intradimer interface 
cannot be directly related to the Y132A mutation, which is at the periphery of the subunit 
(the far left and right of Figure 2a, b), at an interdimer contact (Figure 1) not at the 
intradimer interface.  
 
When Y132A dimers are aligned together and against dimer from capsid, the overall, 
the RMSD for α carbons between any pair is about 2 Å (Table 2), but this average 
misses the systematic structural changes. Visual examination of the overlays reveals an 
underlying constant substructure, or chassis, that is attached by hinges to three 
subdomains (Figure 2c). Using this chassis as the basis for alignment reveals 
systematic structural changes. When the capsid and Y132A dimer forms are aligned 
based on the chassis of one half dimer, the chassis of the other half dimer remains in 
register (Figure 2c). The RMSD between α carbons of the chassis domains from the 
three Y132A dimers and a capsid dimer is about 0.6 to 0.8 Å (Table 2, supplementary 
Table S1), which is close to the uncertainty of atomic position predicted for a structure 
at this resolution and level of refinement by Luzzatti and Sigma A analyses implemented 
in the REFMAC refinement program (33). Thus, the chassis subdomain is discontinuous 
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but structurally well-conserved from free dimer to capsid. In our structure there is a 
disulfide is at the dimer interface between dimer-related C61 residues, also observed in 
capsid. Because this disulfide, which forms an intradimer crosslink, is not likely to be 
present in authentic cytoplasmic assembly we examined its effect in solution studies 
described later in this paper. 
 
In dimers aligned based on the chasses, there are three obvious sub-domains that have 
moved relative to their position in the capsid conformation (Figures 2b, c, 3). We refer to 
these subdomains as the fulcrum helix (residues 10-25), the spike tip (residues 63 – 
94), and the C-terminal interdimer contact (residues 111 to the C-terminus). As noted 
previously, the spike tip in A, D, and E subunits are not capsid-like. However, the spike 
tips from B, C, and F, the fulcrums, and the contact subdomains appear to move as rigid 
bodies based on their structures and positions in the capsid form. The fulcrum is 
constrained by both the spike and the contact domain and can mechanically link these 
two domains. The intersubunit contact domain adopts a range of positions in the Y132A 
dimers. Because the contact domains have not changed their tertiary structure 
appreciably, they are able to form capsid-like contacts (Figure 1), but the higher order 
structural changes prevent propagation of assembly. Because subdomain movement is 
hinged to the chassis, the greatest displacement from the capsid conformation is at the 
subdomain periphery, a Cα displacement by as much as 9Å at the spike tip and 
intersubunit contact subdomains (Figure 2c). 
 
Movement of the subdomains relative to the chassis is facilitated by amino acid hinges: 
glycines at positions 10, 63, 94, and 111 and a proline at position 25 (Figure 3). Though 
glycine is uncommon in α helices and is considered helix-breaking, glycines at positions 
63 and 94 are conserved in HBV core protein sequences (22) resulting in a hinge that 
cuts right through a four-helix bundle. Mutational analysis supports a biological role for a 
hinge in the spike : residue 97 (Phe in this structure, Ile in other HBV strains) in the 
chassis domain forms a large part of the base through which the spike tip interacts with 
the chassis; mutation of this residue to Leu is known to result in phenotypic changes in 
cell culture (50, 51) that correlate with enhanced in vitro assembly (11). The changed 
positions of these domains suggests that dimers are highly dynamic. However, 
subdomains do not show evidence of any concerted molecular motion of subdomains 
within the crystal (as would be detected in TLS refinement (33)). We thus hypothesize 
that the movement of these domains results in a conformational switch between 
assembly-active and -inactive states (described in the discussion). 
  
 
Implications of dimer structure to antigenicity 
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The Cp149-Y132A structure provides a clear explanation for the differential antigenicity 
of capsid and dimer. In both capsid and dimer contexts, one of the major antigenic sites 
of the core protein is the tip of the spike (37). Cryo-EM structures of capsid-FAb 
complexes show that the binding sites for many such antibodies include the loops at the 
tips of both half-dimers (1, 14). In the free dimer structure, the spike tip is grossly 
distorted compared to the capsid form. The spike tip subdomain of one half dimer (B, C, 
and F) is very similar to the equivalent region in a capsid dimer, allowing unambiguous 
alignment of the tip from that half-dimer (Figure 4).  However, in that alignment, the loop 
from the other subunit of the free dimer (A, D, and E) adopts a non-capsid conformation 
which, combined with the quaternary changes, results in a unique dimer epitope. In this 
alignment, the α carbons of this second loop are displaced by up to 10 Å from the 
equivalent residues in the dimer from capsid. The flexibility of the free dimer (this 
structure) and dimer in the context of capsid (4) suggest that it is possible for dimer to 
transiently remodel to other alternative conformations resulting in a broad range of 
selectivity/specificity (1). 
 
The role of the chassis intradimer disulfide to self-assembly 
This crystal structure has an intermolecular disulfide (C61-C61) at the dimer interface 
within the chassis domain (Figure 5a). Crystal structures of capsid, even with a C61A 
mutation (5), indicate that the conformation of capsid is conducive to disulfide formation. 
However, a disulfide would not be expected for free dimer in the reducing environment 
within a cell.  Thus we ask whether the structure of the oxidized chassis domain is an 
accurate representation of the reduced form.  It is clear that in the wild type protein, both 
reduced and oxidized forms are assembly competent (unpublished data). We tested the 
structural and dynamic constraints that the disulfide may impose on the free dimer by 
examining co-assembly reaction with reduced and oxidized Cp149-Y132A. 
 
Previously, we observed that Cp149-Y132A can co-assemble with assembly competent 
Cp (7). To separate the effects of the disulfide in the Y132A mutant from a disulfide in 
the assembly-competent Cp149, co-assembly reactions were carried out using a Cp149 
mutant in which cysteine 61 has been mutated to a serine; this mutant displays normal 
extent and kinetics of assembly (unpublished data).  Cp149-Y132A was either allowed 
to partially air oxidize or was reduced by the addition of 5% β-mercaptoethanol (βME).  
The oxidation state was verified by non-reducing SDS-PAGE; oxidized protein was 
crosslinked by the intradimer disulfide and ran as twice the weight of the monomer 
(Supplementary Figure S3). 
 
The most striking result was observed in assembly reactions run at 23°C. As a control, 
we show here that Cp149-C61S assembles normally in the presence or absence of 
βME (Figure 5b).  When 10 µM oxidized Cp149-Y132A (approximately 1:1 
oxidized:reduced) was included in co-assembly reactions with 5 µM Cp149-C61S, 
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results indicate that the oxidized mutant participated in assembly but did not appreciably 
change the rate of nucleating capsid formation. We observed that the yield of capsid 
increased, indicating co-assembly. The rate of capsid formation at longer times, which is 
proportional to the nucleation rate (19), did not change compared to the control reaction, 
suggesting that either the Y132A mutant does not participate in nucleation, or its effect 
on nucleation rate is exactly balanced by its concentration (7).  However, when reduced 
Cp149-Y132 was used in co-assembly reactions, there was a dramatic decrease in the 
amount of capsid produced over a 24 hour period. In the first hour after initiating 
assembly, the oxidized and control reactions were >50% complete, while no assembly 
was detected with reduced Cp149-Y132A (Figure 5b).  When this reaction was repeated 
at 37°C, the co-assembly reaction, while still slowed, had a much greater yield of 
capsid; it appeared to be approaching the same final extent of assembly as the reaction 
with Cp149-C61S alone (Supplementary Figure S4). This suggests that the reduced 
Cp149-Y132A actually inhibits nucleation. If the mutant simply did not participate in 






The structural differences between the free dimer and dimer from capsid strongly 
suggest a correlated movement of subdomains, consistent with the allostery hypothesis. 
Movement of the spike tips from the dimer to capsid conformations shifts the position of 
adjacent fulcrum helices, which in turn shift the intersubunit contact domain. 
Conversely, removing structural constraints at the intersubunit contact domains, such as 
by release of a dimer from a capsid, will shift the fulcrum helices and allow the spike tip 
to relax. These movements could be further amplified by changes in the chassis 
subdomain related to disulfide reduction. This correlated movement is consistent with 
the propagated change induced by a capsid-binding peptide examined in detail by NMR 
(20) and with the cooperative binding of zinc ions to free dimer observed using intrinsic 
protein fluorescence  (41).  The absence of major refolding of the protein is in 
agreement with published CD and NMR data (20, 39). 
 
Results from the NMR study of unassembled HBV dimer, equivalent to Cp149 (20), 
bears comparison to our structure. To maintain the dimeric state, the NMR sample was 
examined at pH 9.5, which prevented assembly but also raises barriers to a more 
complete analysis. As with our crystal structure, they observed essentially the same 
secondary structure as in the capsid state. Unlike our near neutral pH asymmetric 
dimer, their pH 9.5 structure appears symmetrical based on overlap of TROSY 
crosspeaks.  In the NMR paper, the authors also observed that a peptide, which binds 
at the spike tip (3), bound with a stoichiometry of one per Cp dimer and induced 
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conformational change and asymmetry, indicated by shifts, splitting, or disappearance 
of peaks corresponding to about 30% of the protein. Most of these residues were within 
the upper half of the spike or close to hinges in the spike and fulcrum subdomains, 
areas predicted from our structure to have the greatest opportunities for correlated 
conformational response to outside stimulus.  
 
The differences between the free dimer structure we present in this report and 
the symmetrical dimer from capsid are not artifacts of the Y132A mutation nor of 
packing contacts. The mutation is located in the contact subdomain, a helix-turn-
extended structure distant from the spike or fulcrum helix.  Though the contact 
subdomains are in different positions with respect to the chassis, all six 
crystallographically independent examples (A through F) presented in this paper are 
essentially the same as in the capsid structure. The Y132A mutation does not alter local 
tertiary structure.  Similarly, crystal packing contacts cannot be blamed for the gross 
structural differences between free and capsid conformations of dimer. All three Y132A 
dimers have similar asymmetric conformations (Figure 2a). The asymmetry is most 
obvious in complementary pairs of helices that form the spike at the dimer interface 
(Figure 2a, d). Though the asymmetry is approximately the same, the packing 
environments of the three dimers are crystallographically independent of one another. 
Thus, the asymmetric dimers with mobile subdomains, presented here, is an accurate 
representation of at least some of the conformations available to free dimer.  
 
The Cp149-Y132A free dimer structure and the apparent allosteric nature of the protein 
shed light on the basis of the antiviral mechanism of heteroaryldihydropyrimidines 
(HAPs). HAPs accelerate assembly, strengthen protein-protein interactions, and lead to 
assembly of aberrant particles (40). In a capsid-HAP complex crystal structure, HAP fills 
a pocket at the interface between two dimers to improve packing at the cost of slightly 
distorting the geometry of the contact (5, 6). In free dimer, the HAP binding site is 
framed by residues from the static chassis and two mobile subdomains: the fulcrum and 
the interdimer contact (Figure 3). Chassis residues that contribute to the HAP site are 
mainly from the base of the helix bundle (residues 29-34 and 101-110). The mobile 
components of the HAP site are the fulcrum residues 23 to 25, including hinge Pro 25 
and contact subdomain residues 114-118 and 138-140. This model for the HAP site 
suggests that HAPs non-covalently crosslink subdomains in the assembly-active 
conformation, jump-starting assembly nucleation. Thus, HAPs are able to circumvent a 
major barrier to initiating assembly. 
 
We tested co-assembly of reduced and oxidized Cp149-Y132A with a wildtype-like 
mutant and observed effects related to the disulfide within the chassis region.  Oxidized 
Cp149-Y132A co-assembled with Cp149-C61S. Pure reduced Cp149-Y132A inhibited 
capsid formation, acting as a sort of competitive inhibitor of assembly. The presence of 
the disulfide and the presumed restriction of chassis dynamics increase association of 
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Cp149-Y132A.  Conversely, the reduced form of the protein seems to poison the 
assembly.  The lack of the disulfide may favor the inactive state, allow unconstrained 
motion of the chassis, or allow a different conformation of the chassis domain from that 
observed in the structure. This indication that assembly is affected by dynamics of free 
dimer (within the chassis) or structural change within the dimer indicates a direction for 
further structural and analytical studies. Thus for reduced dimer, the likely cellular form 
of Cp, allosteric activation of assembly is far more critical for assembly. 
 
Allostery provides a rationale for in vivo behavior. It also substantively alters quantitative 
models of assembly and disassembly. Simulations of assembly-disassembly reactions 
suggest that conformational change is imposed on HBV by induced fit. As in previous 
studies (27, 39, 54, 58), we simulated assembly as a bulk reaction where each capsid 
starts with a nucleation event followed by a cascade of second order reactions adding 
one dimer at a time. We consider three scenarios for incorporating allostery: (i) sudden 
activation of all subunits, (ii) an equilibrium where only a small fraction of subunit is in 
the assembly-active state, and (iii) induced fit where activated subunits are required for 
nucleation but inactive subunits can add to a growing polymer. The first two alternatives 
simply do not work. If dimer conformational changes were induced all at one time the 
high association energy would trump nucleation, resulting in a kinetic trap with many 
partially assembled fragments; such kinetic traps have been observed when assembly 
was “over-nucleated” by Zn++ (41). If assembly were based on an equilibrium between 
active and inactive Cp, the low concentration of reactant combined with strong 
association energy necessary to drive assembly at low concentration would create a 
reaction starved for intermediates that stalled far short of equilibrium – illustrated in 
kinetic simulations (19) and line tension arguments (8).  
 
In contrast, induced fit provides a structural and energetic basis for a nucleation step to 
generate the initial template for assembly. In this scenario, the kinetic basis for 
nucleation is the low probability of collision between assembly-active molecules. 
Elongation based on induced fit, a process also termed autostery (10), allows the 
common assembly inactive state to participate in assembly. Such collisions are likely 
and fast (diffusion-limited). Induced fit indicates that the assembly-inactive subunit in   
this complex undergoes a very fast intramolecular structural transition to the assembly-
active state, which results in a more stable complex. Because the induced fit effect does 
not affect the collision rate, simulations show a typical, efficient, nucleated assembly  
reaction (Figure 6a) (19, 53, 58). Induced fit is consistent with the weak net association 
energy observed experimentally (12): the sum of the strong association energy of the 
assembly-active state and the energetic cost of the conformational change.  
 
Though induced fit shows no discernable effect on assembly kinetics, there is a 
dramatic effect in kinetic simulations of capsid disassembly (Figure 6b). The difference 
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between association energy of the activated state and net association energy 
contributes to the hysteresis to dissociation; where hysteresis is markedly enhanced 
stability of capsids to dissociation compared to the expectation based on association 
energy and kinetics (23, 39). In disassembly of induced fit capsids, release of subunits 
requires breaking the strong interactions of the assembly-active state. The overall effect 
is that the model (and any other virus that incorporates an induced fit mechanism) will 
demonstrate a remarkable stability and persistence while between hosts (Figure 6b). 
Such capsids can persist as metastable structures that are primed for dissociation in 
response to an appropriate stimulus such as pH or a receptor.  
 
The hinged movement of the subdomains and the structural differences between the 
three Cp149-Y132A dimers in the crystallographic asymmetric unit and their comparison 
to a dimer from capsid strongly suggest that the actual protein is dynamic. The relatively 
unconstrained reduced free dimer is likely to have greater dynamic freedom to search 
for the biologically relevant binding partners, that may trigger the allosteric change that 
initiates assembly.  We propose that allosteric regulation of assembly and induced fit, 
with their biological, kinetic, and energetic implications, are a common mechanism of 
ensuring specificity and fidelity of capsid assembly in viruses. The allosteric effector that 
controls HBV assembly in vivo is probably related to the complex of viral RNA and 
reverse transcriptase. The allostery hypothesis suggests that most self-assembling 
viruses will have a natural allosteric effector and these are well worth identifying.  The 
HAP molecules are artificial allosteric effectors of HBV assembly. Functionally similar 
effectors are likely to have antiviral effect in any self-assembling virus that incorporates 
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Table 1. Data and Refinement Statistics 
 
Crystal  
  Space group P31 
  Unit cell dimensions  a =  b = 104.16 Å ,  c = 86.91 Å;      
α = β = 90°, γ = 120° 
  Resolution limit (Å) 25.32 - 2.25  (2.30 - 2.25)‡  
  Completeness  99.96%  (99.92%) 
  Redundancy 4.5 (4.4) 
  I / σ 41.8 (5.34) 
  Rmerge  .076 (.572) 
 
Refinement:  
Resolution 2.25 Å 
Unique reflections  47650    (3506) 
R 21.7%   (27.8%) 
Rfree 26.4%   (32.5%) 
Asymmetric unit  Trimer of dimers 
No. atoms  
  Non-hydrogen protein atoms 6729 
  Water molecules 213 
Mean B-factor 
 
   Protein 48.3 
   Water 48.8 
Ramachandran plot  
  Residues in most favored regions  89.1% 
            in additionally allowed regions    8.7% 
            in generously allowed regions    1.1% 
            in disallowed region    1.1% 
Non-ideality of   
        bond angles  1.926°  
        bond lengths 0.020Å 
 




Table 2.  Comparison of Cp149-Y132A dimers with an AB dimer from capsid 
(RMSD) 
 
 1QGT-AB 1QGT-DC 1QGT-FE 
overall 1.80 Å    2.30 Å    2.82 Å 
chassisa  0.68 Å    0.79 Å    0.82 Å 
a - The chassis domain, residues 1-10, 26-62, and 95-110, is discontinuous with respect 
to primary structure. For this comparison, the chasses of the Y132A A, D, and E 






Figure 1.  The crystallographic asymmetric unit is a trimer of dimers arranged as broken 
triangle or one turn of helix. Cp149-Y132A dimers. (a) Icosahedral HBV capsids can be 
considered arrays of triangular trimers of dimers. A threefold symmetric trimer is 
highlighted using yellow and green surface shading. Such triangles are the fundamental 
quaternary structure in HBV capsids; a trimer of dimers has been implicated in 
nucleating capsid assembly (58). (b, c) The asymmetric unit of Cp149-Y132A as a 
ribbon diagram (b) and surface shaded (c). Dimers are labeled AB, CD, and EF (inset). 
The mutated residue, Y132A, is identified by the pink spheres at the ends of each 
dimer. The B-C and D-E interdimer contacts resemble those found in capsid. The F 
subunit passes under the A subunit and does not make an equivalent contact. The 
broken triangle of the Cp149-Y132A asymmetric unit suggests that interprotein contacts 
between mutant dimers are not strong enough to force a planar quaternary structure, 
the likely the basis for their inability to nucleate capsid assembly. 
 
Figure 2. Overlays of dimers show asymmetry and divergence from capsid structure 
viewed tangent to the virus surface. (a) Cp149-Y132A dimers are asymmetric and 
structurally unique. The monomers fall into two structural classes based on the 
conformation of the long helices at the intradimer interface. Even so, obvious 
differences are apparent at the tip of the spike (top center of the figure) and at the turn 
at the end of the interdimer contacts. (b) An overlay of the EF Cp149-Y132A dimer 
(colored dark blue and marine blue, respectively, as in panel a) and dimer from capsid 
(AB from 1QGT (48) in yellow) to allow comparison of free and dimer structures. There 
are substantial differences between the two conformers at the periphery even though a 
central core, or chassis, is identical. Unlike Cp149-Y132A, the dimer from capsid has 
well maintained twofold symmetry (Supplementary data). (c) For quantitative analysis 
(this panel, as with all overlays in this figure), chassis alpha carbons (1-10, 26-62, and 
95-110) of A, D, and E subunits of Cp149-Y132A were aligned with equivalent residues 
from a capsid A subunit; distances are reported between equivalent alpha carbons 
throughout the dimers.  Though not specifically constrained, both half dimers show the 
same pattern of similarity and difference. (d) A side by side comparison of the E (left) 
and F (right) halves of the four helix bundle “spike” shows the asymmetry of the Cp149-
Y132A dimers. This view shows the complementary surfaces that are buried at the 
dimer interface. The segment from A54 to W71 have approximately the same alignment 
to facilitate comparison. Note that residues 79 -80 are part of the random coil turn in 
chain F.  
 
Figure 3. Free dimers have subdomains connected to a chassis by flexible hinges. (a) 
Based on molecular displacement (Fig 2c), subdomains have been color coded and 
labeled.  Domain junctions are flexible hinges (shown in CPK representation): Gly10 
and Pro25 delineate the fulcrum domain (green), Gly63 and Gly94 the spike tip 
(copper), and Gly111 the C-terminal interdimer contact domain (red). The structurally 
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invariant chassis is shown in blue.  (b) An assembly effector HAP molecule (magenta) 
and adjacent residues (cyan), modeled on the basis of a capsid-HAP co-crystal 
structure (5), non-covalently links the flexible contact and fulcrum domains with the 
chassis. This stabilization may explain HAP’s assembly accelerating activity. 
 
Figure 4.  The major Cp epitope, the spike tips at the dimer interface, is radically 
different in free and capsid forms. In many capsid-antibody complexes the epitope 
includes both half dimers (24). The structural difference is made clear in this overlay of 
Y132A and capsid dimers  (colored as in Figure 2), where alignment is based on alpha 
carbons of the structurally similar component of the spike tips  (e.g. residues 70 – 85 of 
the Cp149-Y132A E subunit with the corresponding residues of a capsid A subunit). In 
the side view (a) and top view (b), the displacement of the alpha carbons of the F 
subunit spike tip is by as much as 10Å. 
 
Figure 5.  Chassis domain allostery is affected by the presence or absence of an 
intradimer disulfide.  (a) Cysteine 61 is a conserved residue at the dimer interface in the 
chassis domain (domains colored as in Figure 3). It readily oxidizes to a C61-C61 
disulfide, which may constrain chassis dynamics and conformation. (b) The presence or 
absence of the chassis domain disulfide in Y132A affects co-assembly with Cp149-
C61S at 23°C. The amount of capsid and dimer was evaluated by size exclusion 
chromatography a specified time after assembly was induced. The capsid assembly 
rate correlates directly to nucleation rate (19).  The assembly-competent C61S mutant 
was used for these comparisons as it assembles the same in oxidizing and reducing 
environments (open and closed squares, respectively). Oxidized (open triangles) and 
reduced (closed triangles) 20 µM Cp149-Y132A was co-assembled with 5 µM Cp149-
C61S. While partially oxidized Cp149-Y132A was able to participate in normal 
assembly, reduced Cp149-Y132A poisons the reaction, slowing the nucleation rate and 
decreasing the extent of assembly. 
 
Figure 6.  Structural differences support allostery and an induced fit model of assembly 
that causes a dramatic hysteretic stabilization of capsids. (a) In assembly, the limiting 
step is the kinetically controlled association. The subsequent allosteric change cannot 
be discerned. Thus, assembly kinetics are the same for simple association and induced 
fit. In disassembly, the limiting step is breaking the strong interactions between the 
complex (capsid or intermediate) and the assembly-active Cp. Assuming the on-rate for 
active and inactive states is the same, the difference in association constant will be 
reflected in a proportionately slower off rate. (b) Simulations of disassembly for induced 
fit and non-allosteric reaction where both have net ∆Gcontact=-3.1 kcal/mol.  Dissociation 
in the induced fit simulation was not detectable in this graphic representation over a 
160,000 s simulation. Simulations were calculated for a 30-subunit capsid using master 
equations (19, 55) 






